$RMTG News

RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind

RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit

RMTG Subsidiary CELLGENIC Expands into Dominican Republic with New Distribution Partnership

RMTG Expands into Brazil with Strategic Representation Agreement

RMTG's ISSCA Regenerative Medicine Global Summit 2025 Concludes in Cancún with Full Attendance from 30+ Countries

RMTG Partners with BKFC as Official Regenerative Medicine Provider

RMTG Subsidiary Cellgenic to Host Soft Opening of Advanced Cell Therapy Manufacturing Lab in Cancun During September ISSCA Global Summit

RMTG Expands to Northern Argentina and Paraguay with New Affiliate Partnership

RMTG's Successful ISSCA Buenos Aires Argentina Event Draws Hundreds of Physicians, Announces Seven Additional Training Events in 2025

RMTG Expands to Puerto Rico with New Affiliate Partnership

Regenerative Medical Technologies Group Increases Q1 2025 Sales By 67% Over Q1 2024 and Achieves Operating Profit for the Quarter of $134,000

Regenerative Medical Technologies Group Increased 2024 Sales by 70% Year Over Year with Increased Q4 Sales by 146% Year Over Year and Achieved Positive Operating Income for 2024

RMTG Achieves Operational Profitability Expands Sales by 52% for Q3 Year Over Year and Reaches Gross Profit Margin of 75% for Q3

Regenerative Medical Technology Group Announces the Opening of New Clinic in Dubai on November 23

Meso Numismatics Changes Name to Regenerative Medical Technology Group and Ticker Symbol to RMTG